Knowra Midazolam Midazolam Midazolam is a short-acting benzodiazepine that enhances GABA signaling in the brain. It is used for sedation, anxiety relief, seizure control, and anesthesia induction.
GABA-A receptor : A ligand-gated chloride channel that mediates much of the brain’s fast inhibitory signaling. Midazolam binds to this receptor complex and strengthens GABA’s inhibitory effect.
Procedural sedation : Medication-induced reduction in awareness and anxiety during a diagnostic or therapeutic procedure. Midazolam is commonly used to produce sedation and amnesia during procedures.
Lorazepam : A benzodiazepine used for anxiety, seizures, and sedation, with a longer duration than midazolam in many settings. Its longer action can make it preferable when sustained seizure control is needed.
Respiratory depression : Abnormally slow or inadequate breathing that reduces oxygen intake or carbon dioxide removal. Midazolam can suppress breathing, especially with opioids or other central nervous system depressants.
Pharmacokinetics : The study of how the body absorbs, distributes, metabolizes, and eliminates drugs. Midazolam’s rapid onset and variable duration depend on these processes.
Benzodiazepine : A class of drugs that modulate GABA-A receptors and commonly produce anxiolytic, sedative, and anticonvulsant effects. Midazolam belongs to this drug class and shares its characteristic receptor action.
Status epilepticus : A prolonged seizure or recurrent seizures without recovery that require urgent treatment. Midazolam can rapidly stop seizures, including when administered outside a hospital.
Diazepam : A long-acting benzodiazepine used for anxiety, muscle spasm, and seizure treatment. Diazepam’s longer persistence contrasts with midazolam’s rapid onset and relatively short clinical action.
Anterograde amnesia : Impaired formation of new memories after an event or drug exposure. This effect is often useful during procedures but can complicate consent and recovery.
First-pass effect : Metabolism of an orally absorbed drug in the intestine and liver before it reaches systemic circulation. Extensive first-pass metabolism limits oral midazolam bioavailability.
Show all 26